DigestRedComo funciona
Red
/
Empresas
Ci
No verificado

City Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

7 Comunicados de prensa

Ver todos los comunicados de prensa
08/06/2026
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/05/2026
Industria
Oncología
Salud
Sanidad
Farmacéutica
Biotecnología
City Therapeutics Presents Preclinical Data on Next-Generation Investigational RNAi Therapy CITY-RBP4 for Treatment of Stargardt Disease at ARVO 2026 Annual Meeting
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0
10/11/2025
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Sanidad
City Therapeutics Announces Submission of Clinical Trial Application for CITY-FXI, an Investigational RNAi Therapeutic for the Treatment of Thromboembolic Diseases
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0
17/04/2025
Mercado laboral
Biotecnología
Farmacéutica
Salud
City Therapeutics Expands Executive Team and Board of Directors
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0
10/01/2025
Mercado laboral
Industria
Salud
Biotecnología
Sanidad
Farmacéutica
Óptica
City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0
07/01/2025
City Therapeutics Appoints Andy Orth as Chief Executive Officer
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0
08/10/2024
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine
Fuente
City Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0